Insights into recent findings and clinical application of YAP and TAZ in cancer

JM Franklin, Z Wu, KL Guan - Nature Reviews Cancer, 2023 - nature.com
Decades of research have mapped out the basic mechanics of the Hippo pathway. The
paralogues Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding …

[HTML][HTML] Targeting breast cancer stem cells

L Zhang, W Chen, S Liu, C Chen - International journal of …, 2023 - ncbi.nlm.nih.gov
The potential roles of breast cancer stem cells (BCSCs) in tumor initiation and recurrence
have been recognized for many decades. Due to their strong capacity for self-renewal and …

New insights into the ambivalent role of YAP/TAZ in human cancers

J Luo, L Deng, H Zou, Y Guo, T Tong, M Huang… - Journal of Experimental …, 2023 - Springer
Hippo signaling was first identified in Drosophila as a key controller of organ size by
regulating cell proliferation and anti-apoptosis. Subsequent studies have shown that this …

New insights into YAP/TAZ-TEAD-mediated gene regulation and biological processes in cancer

Y Zhao, M Sheldon, Y Sun, L Ma - Cancers, 2023 - mdpi.com
Simple Summary The Hippo pathway is crucial for regulating cell growth, organ size, and
tissue regeneration. When this pathway goes awry, it can lead to uncontrolled cell growth …

[HTML][HTML] YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases

JK Dermawan, EM Azzato, SD Billings, KJ Fritchie… - Modern Pathology, 2021 - Elsevier
Abstract YAP1-TFE3-fused hemangioendothelioma is an extremely rare malignant vascular
tumor. We present the largest multi-institutional clinicopathologic study of YAP1-TFE3-fused …

Loss of CDKN2A Cooperates with WWTR1(TAZ)–CAMTA1 Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma

CN Seavey, A Hallett, S Li, K Che… - Clinical Cancer …, 2023 - aacrjournals.org
Purpose: Epithelioid hemangioendothelioma (EHE) is a vascular sarcoma caused by the
WWTR1 (TAZ)–CAMTA1 (TC) gene fusion. This fusion gene has been observed in almost all …

TAZ/YAP fusion proteins: Mechanistic insights and therapeutic opportunities

K Garcia, AC Gingras, KF Harvey, MR Tanas - Trends in cancer, 2022 - cell.com
The Hippo pathway is dysregulated in many different cancers, but point mutations in the
pathway are rare. Transcriptional co-activator with PDZ-binding motif (TAZ) and Yes …

Vasculature is getting Hip (po): Hippo signaling in vascular development and disease

S Kobayashi, AG Cox, KF Harvey, BM Hogan - Developmental Cell, 2023 - cell.com
The Hippo signaling pathway regulates developmental organ growth, regeneration, and cell
fate decisions. Although the role of the Hippo pathway, and its transcriptional effectors YAP …

Hippo Signaling at the Hallmarks of Cancer and Drug Resistance

R Kumar, W Hong - Cells, 2024 - mdpi.com
Originally identified in Drosophila melanogaster in 1995, the Hippo signaling pathway plays
a pivotal role in organ size control and tumor suppression by inhibiting proliferation and …

The TAZ-CAMTA1 fusion protein promotes tumorigenesis via connective tissue growth factor and Ras–MAPK signaling in epithelioid hemangioendothelioma

S Ma, R Kanai, AV Pobbati, S Li, K Che… - Clinical Cancer …, 2022 - AACR
Purpose: A consistent genetic alteration in vascular cancer epithelioid
hemangioendothelioma (EHE) is the t (1; 3)(p36; q25) chromosomal translocation, which …